Boule Diagnostics AB

Boule Diagnostics AB is a global diagnostics company based in Sweden, with over 60 years of experience in automated hematology testing. The company specializes in decentralized blood analysis, offering diagnostic solutions primarily for small and medium-sized healthcare settings, including hospitals, clinics, and laboratories in both human and veterinary markets. Boule develops and manufactures a variety of diagnostic instruments and consumables, such as hematology analyzers and clinical chemistry analyzers, along with associated reagents and controls. Their automated hematology analyzers are widely used for general health screenings, providing important early indicators of disease. Additionally, Boule's US division, Clinical Diagnostic Solutions, offers customized development and manufacturing services, collaborating with international medical device companies to create private-label and OEM products. With subsidiaries in several countries and a global sales network of over 200 distributors, Boule ensures effective customer support through local sales and service personnel. The company is publicly traded on Nasdaq Stockholm and has reported stable financial performance, reflecting its strong market position and operational efficiency.

• Employees 200
• Founded 1956
• Annual Revenue $50841000